Delivery Order SPE2DB22D1052-SPE2DB25FU8AR

Award Date 12/1/24
Potential Completion Date 12/2/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB25FU8AR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,006.15 Firm Fixed Price Delivery Order is for the supply of Otezla 30 mg tablets, a specialty pharmaceutical product used to treat certain medical conditions. The contract has an ultimate completion date of December 2, 2024 and was awarded on December 1, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a major distributor of medical products to federal agencies, including the military, AmerisourceBergen plays a critical role in ensuring the availability of essential medications and supplies for service members, veterans, and other federal beneficiaries.

Generated 3/2/25, 1:42 AM